How TJ Frost Saw the Power of Medical Cannabis and Built a Brokering Business Around It

“Cannabis insurance is a whole different ball game from when I started 11 years ago,” said TJ Frost, president of Symphony Grow, a specialty business of Symphony Risk Solutions. “At that time, Lloyd’s had just pulled out, so everyone was looking for coverage. It was dialing for dollars, not for clients, but for carriers.”
That was not necessarily because of carriers’ reticence to the business itself, but mostly because of pragmatic underwriting realities. As a de novo sector, cannabis did not have the data to support rating. There was also the complication of dealing with a substance that is still not federally legal and remains subject to a patchwork of state regulations. Some states allow only medicinal use; some also allow recreational use. Some don’t allow use at all. Some states require only general liability. Others require product liability as well as general.
Against that backdrop few underwriters would commit to the startup costs of developing coverage for a completely new business sector with a completely new and untested supply chain. In 2013 and ’14, only a handful of carriers would take on the risk, Frost recalled. That has since grown to more than 40.
“Everything has gotten better. We have more than 40 carriers and all lines of coverage available to us now. When I started, it was just the basic coverages. The national insurance market is hard today, but for cannabis, we are now in the softest market ever. When I started, people were paying $1 million in premium for $1 million in coverage with a $1 million retention. Now those same limits cost $40,000.”
Cannabis In 2025
The U.S. cannabis market was estimated at $38.5 billion in 2024 and is expected to grow at a CAGR of 11.51% from 2025 to 2030, according to Grand View Research: “Growing acceptance of its use for medical purposes and rising legalization are the key factors driving growth. Increasing research activities on the use of cannabis and its medicinal properties have led to its increased use to treat various chronic conditions.”
The Food and Drug Administration approved the use of cannabis-derived drug formulations for treating seizures and chemotherapy-induced side effects. At the same time, popular attitudes are becoming more favorable. A Gallup survey found that about half of adults in the U.S. — across genders, ages and educational backgrounds — have tried marijuana, based on data from 2022 and 2023.
“In addition, there is a high demand for various cannabinoid (CBD)-infused goods, such as oils, beauty products, gummies, and beverages,” noted Grand View. “Other factors contributing to growth include the favorable cultivation norms, which help cater to the biomass demand in the U.S. Florida, Oregon, Nevada, California, Washington and Colorado are major producers of cannabis, owing to favorable climatic conditions and legalization.”
While state-to-state variability remains, as does federal prohibition, Frost reiterated that “everything is getting better. We have a real, viable, insurable industry now. There has been so much progress. Half my time these days is spent helping new carriers come into the business, and I don’t see any pulling back. Policy forms are getting better, and there is consolidation among suppliers for a more robust supply chain.”
The other important aspect of cannabis growth and development is scale. “The sophistication of business is leaps and bounds from where it was 10 years ago,” Frost said. “There is access to capital, and there is access to banking.”
From a Father’s Noble Fight Comes a Son’s Strength
Fost started his career in corporate finance.
He grew up in a small town in Washington, where he resides still today, and went to the University of Washington. But, his career arc completely shifted when his father was diagnosed with cancer. “The chemo and radiation treatments were ruining his life,” Frost said.
“He switched to cannabis and was able to eat and drink and sleep again. It was night and day. About the same time, I was at an impasse in my career. I was being recruited by a major brokerage, and I asked if they had a cannabis practice.”
They did not, so Frost asked if he could start one. He built that practice, and then met Michael Marcon, founder and CEO of Symphony Risk.
“I spent the first several months at the brokerage practice with the people in every aspect of the cannabis business, getting to know them and the whole industry. Then, when we started with Symphony Grow, we built this specialty practice for the industry itself,” he said.
“The big brokerages see the sector as a new source of revenue, which is fair enough. “But we built this business for the clients. If we do what is right for the clients, then we never have to worry about keeping the lights on. Our name is Symphony for a reason. It’s all about playing in-tune together. In four years, we’ve built the business to offices in 11 states with clients all over the country and in Canada.”
Marcon became a mentor for Frost straight away, second only to his father. “My dad was one of the hardest working men I have ever known. He was a great salesman. He could sell a ketchup popsicle to a woman in white gloves,” Frost said. From his mentors, Frost has learned to lead from the front. “Being a leader and being a manager are two different things. It is possible to be good at both, but just being good at one does not mean you are automatically good at the other. Quite to the contrary.”
Given the amount of travel that Frost has to do for work, his ideal vacation is spending time at home with his wife and three young daughters. “Being home is how I love to spend my time, coaching softball and basketball with my girls and date nights with my wife,” he said. &